Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1272 results about "Dosage form" patented technology

Dosage forms (also called unit doses) are pharmaceutical drug products in the form in which they are marketed for use, with a specific mixture of active ingredients and inactive components (excipients), in a particular configuration (such as a capsule shell, for example), and apportioned into a particular dose. For example, two products may both be amoxicillin, but one is in 500 mg capsules and another is in 250 mg chewable tablets. The term unit dose can also sometimes encompass non-reusable packaging as well (especially when each drug product is individually packaged), although the FDA distinguishes that by unit-dose "packaging" or "dispensing". Depending on the context, multi(ple) unit dose can refer to distinct drug products packaged together, or to a single drug product containing multiple drugs and/or doses. The term dosage form can also sometimes refer only to the pharmaceutical formulation of a drug product's constituent drug substance(s) and any blends involved, without considering matters beyond that (like how it is ultimately configured as a consumable product such as a capsule, patch, etc.). Because of the somewhat vague boundaries and unclear overlap of these terms and certain variants and qualifiers within the pharmaceutical industry, caution is often advisable when conversing with someone who may be unfamiliar with another person's use of the term.

Bupropion as a modulator of drug activity

Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Owner:ANTECIP BIOVENTURES II LLC

Dosage forms for Tyk2 inhibitors

Stable and bioavailable formulations and dosage forms comprising a dispersion (e.g., spray-dried dispersion) of solid amorphous 6-(cyclopropancamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide (Formula (I): BMS-986165) in a solid polymer matrix are provided for the treatment of auto-immune and auto-inflammatory diseases such as an inflammatory bowel disease (IBD) and psoriasis.
Owner:BRISTOL MYERS SQUIBB CO

Bactericidal composition containing fluxapyroxad and thiediazole copper

InactiveCN107771825ASynergistic effect is obviousDelay key drug resistanceBiocideFungicidesBacterial compositionPhytophthora sp.
The invention relates to a bactericidal composition containing fluxapyroxad and thiediazole copper. The bacterial composition is compounded from fluxapyroxad and thiediazole copper in a binary mode, wherein a mass ratio of fluxapyroxad to thiediazole copper is (1-50) to (50-1); a mass fraction of fluxapyroxad and thiediazole in the preparation is 1%-80%, and the rest of the preparation is auxiliary components which are allowed to use and are acceptable in a pesticide. A dosage form of the bactericidal composition is missible oil, a suspending agent, wettable powder, a water dispersible granule, emulsion in water, microemulsion, a granule and a micro-capsule. The bactericidal composition is mainly used for controlling plant gray mold, peronospora and phytophthora germs.
Owner:HAILIR PESTICIDES & CHEM GRP

Temozolomide derivative with poly ADP ribose polymerase inhibitory activity and preparation method and application thereof

The invention discloses temozolomide derivatives or pharmaceutically acceptable salts, crystal forms and solvates, wherein the structure of the temozolomide derivatives is shown as a formula I in the specification. According to the temozolomide derivative disclosed by the invention, damage caused by repairing temozolomide by cells is prevented by inhibiting PARP1 protein, so that the purpose of improving the overall anti-glioblastoma effect is achieved. The invention further discloses application of the temozolomide derivative or the pharmaceutically acceptable salt, the crystal form and the solvate to preparation of a PARP1 inhibitor. The invention also discloses application of the temozolomide derivative or the pharmaceutically acceptable salt, the crystal form and the solvate in preparation of medicines for preventing and / or treating tumors. The invention also discloses a pharmaceutical composition, and the pharmaceutical composition takes a safe and effective amount of temozolomide derivative or pharmaceutically acceptable salt, crystal form and solvate as effective components or main effective components, and is prepared into a pharmaceutically acceptable dosage form together with a pharmaceutically acceptable carrier.
Owner:CHINA PHARM UNIV

Dosage composition of complement factor b inhibitor

The present invention belongs to the field of biotechnology. Disclosed is a dosage composition of a complement factor B inhibitor. Specifically, the present invention provides a pharmaceutical composition comprising a compound represented by formula I, an isomer thereof, or a pharmaceutically acceptable salt thereof in a unit dosage form, wherein the mass of the compound or the pharmaceutically acceptable salt thereof is 5-1500 mg based on the free base.
Owner:NANJING CHIA TAI TIANQING PHARMA

Blood-generating preparation for treating male hormone alopecia as well as preparation method and application of blood-generating preparation

The invention discloses a hematopoietic preparation for treating androgenetic alopecia and a preparation method of the hematopoietic preparation. The hematopoietic preparation is prepared from 5-30 parts of radix polygoni multiflori preparata, 5-30 parts of wine ligustrum lucidum ait, 5-30 parts of mulberry, 5-30 parts of eclipta, 5-30 parts of radix paeoniae alba, 5-30 parts of astragalus membranaceus and 5-30 parts of rhizoma cibotii. The medicine composition and the specific dosage are obtained through a large number of experimental screening and clinical medication experience screening. The whole formula takes tonifying liver and kidney and benefiting essence and blood as the monarch, and takes tonifying spleen and qi and removing heat to cool blood as the minister and assistant, based on the traditional Chinese medicine theory that essence is stored in kidney and is warmed on hair, by inhibiting DHT generation, resisting hair follicle apoptosis and improving scalp microcirculation, the traditional Chinese medicine composition has the remarkable effect of treating androgenetic alopecia, is weak in toxic and side effects, and can be prepared into various clinical dosage forms.
Owner:SHAANXI UNIV OF CHINESE MEDICINE

Double-agent copper acid etching solution as well as preparation method and application thereof

PendingCN121951534Asmall amount of variationshort etching timeNon-linear opticsAcid etchingOrganic acid
The invention provides a double-dosage-form copper acid etching solution as well as a preparation method and application thereof. The double-dosage-form copper acid etching solution comprises an agent A and an agent B, the agent A comprises the following components in parts by weight: 15-20 parts of an oxidizing agent, 4-7 parts of an organic acid chelating agent, 0.1-0.5 part of inorganic acid, 0.5-2 parts of alkali, 1-2 parts of a surfactant and 0.01-0.1 part of a metal corrosion inhibitor; the agent B is prepared from the following components in parts by weight: 25 to 30 parts of organic acid chelating agent, 0.2 to 0.5 part of inorganic acid, 15 to 20 parts of alkali, 1 to 2 parts of surfactant and 0.1 to 0.3 part of metal corrosion inhibitor. The double-agent copper acid etching solution provided by the invention can be compatible with etching of Cu / Mo and Cu / MTD film layers, can be compatible with etching of film layers with different thicknesses, and is long in service life, low in CD Bias, free of chamfer cracks, good in residue, small in taper variation and short in etching time.
Owner:NANJING HEXIANDA MICROELECTRONICS TECHNOLOGY CO LTD

Externally applied medicine for incontinent dermatitis and preparation method thereof

The invention provides an external application medicine for incontinent dermatitis and a preparation method thereof. The composition is prepared from active ingredients such as a radix sophorae flavescentis extract, calamine, vitamin E, ceramide, a herba portulacae extract, glycyrrhizic acid, chitosan and colloidal oat powder according to a specific proportion. Moisturizing matrixes such as sodium hyaluronate and glycerol and functional components such as tea tree essential oil are supplemented. And through a preparation process of matching high-speed shearing with ultrasonic dispersion, uniform dispersion and stability of each component are ensured. Experimental results show that the composition shows a remarkable synergistic effect in the aspects of anti-inflammation, antibiosis, skin barrier repair and the like, the comprehensive relieving and repairing effect of the composition is superior to that of a conventional drug control, and all the components and a special preparation process are necessary for achieving the optimal effect. The product has no irritation to human skin, is good in safety, can be prepared into various dosage forms such as cream, hydrogel or spray, and is suitable for nursing and repairing sensitive skin.
Owner:HAINAN WESTERN CENT HOSPITAL (DANZHOU FIRST PEOPLES HOSPITAL HAINAN WESTERN REGIONAL MEDICAL CENT)

Dosage forms comprising a VAV1 degrader

PCT designated stageWO2026013581A1Powder deliverySolution deliveryDiseasePiperidinedione
Disclosed herein are dosage forms comprising a VAV1 degrader. More specifically, disclosed herein are dosage forms comprising 3-(2-chloro-4'-(2-oxopyridin-1(2H)-yl)-[1,1'- biphenyl]-3-yl)piperidine-2,6-dione or a pharmaceutically acceptable salt thereof. These dosage forms are useful, e.g., for treating a subject (e.g., a human subject) having a disorder or disease that can be treated by reducing the level of VAV1, for example an inflammatory or autoimmune disorder, a transplantation setting disorder, or a cancer.
Owner:MONTE ROSA THERAPEUTICS AG

Treatment of myopic progression

An ophthalmic composition or dosage form can include a therapeutically effective amount of a copper-containing agent that is sufficient to increase corneal lysyl oxidase activity in an eye of a subject in an amount sufficient to treat myopic progression and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat or prevent progression of myopia by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
Owner:UNIV OF UTAH RES FOUND

Application of tea extracellular vesicles in preparation of product for preventing and / or treating UVB-induced skin photoaging

The invention discloses application of tea extracellular vesicles in preparation of a product for preventing and / or treating UVB-induced skin photoaging, and belongs to the technical field of application of the tea extracellular vesicles. The tea extracellular vesicles are derived from tea leaves and / or stem leaves and are prepared by a method of combining enzymolysis, multi-stage filtration and ultracentrifugation, and the particle size of the tea extracellular vesicles is mainly distributed in a range of 60-100nm. Experiments show that the tea extracellular vesicles can effectively reduce active oxygen accumulation and lipid peroxidation caused by UVB radiation, repair mitochondrial membrane potential and inhibit expression of matrix metalloproteinase and inflammatory factors, so that photoaging symptoms such as skin wrinkles, erythema and barrier function damage are relieved. The tea extracellular vesicle provided by the invention has the advantages of natural raw materials, good biocompatibility, small side effect and the like, can be used for preparing a plurality of external dosage forms such as gel, cream, spray and the like, and provides a safe and effective new natural product choice for prevention and treatment of skin photoaging.
Owner:XIAMEN BIYAN BIOTECHNOLOGY CO LTD

Amino acid composition for treating alopecia and application of amino acid composition in preparation of medicine for treating alopecia

The invention discloses an amino acid composition for treating alopecia and application of the amino acid composition in preparation of a medicine for treating alopecia, and belongs to the field of medicine configuration products, the amino acid composition is composed of a targeting core intervention component and an auxiliary strengthening synergistic component, the targeting core intervention component is prepared from 30-50 parts of arginine, 50-155 parts of lysine and 50-120 parts of glutamic acid, and the auxiliary strengthening synergistic component is prepared from an auxiliary strengthening synergistic component and an auxiliary strengthening synergistic component. 10 to 40 parts of cysteine and 20 to 60 parts of leucine; the auxiliary strengthening synergistic component is prepared from 15 to 45 parts of tyrosine, 15 to 40 parts of glycine, 10 to 40 parts of glutamine, 20 to 35 parts of serine, 5 to 25 parts of alanine, 2 to 20 parts of aspartic acid and 15 to 35 parts of phenylalanine; the composition can be used as an active ingredient to be prepared into different dosage forms such as a pigmentum, a spray, an ointment and a liniment, is applied to prevention of alopecia and promotion of hair growth, and has a remarkable treatment effect.
Owner:JILIN AGRICULTURAL UNIV

Postbiotic composition for effectively inhibiting dental caries in oral cavity and preparation method thereof

The invention belongs to the technical field of biomedical treatment and biological fermentation, discloses a metagen composition for effectively inhibiting oral dental caries and application thereof, and aims to solve the problems of great side effect, weak effect and unknown mechanism of the existing dental caries prevention and treatment means. The composition is prepared by mixing a metagen 1 which is prepared by fermenting lactobacillus salivarius Postbio-YY with a metagen 2 which is prepared by fermenting lactococcus lactis Postbio-F3 and lactobacillus paracasei Postbio-P6 step by step. In the preparation process, the active ingredients are reserved by accurately controlling the fermentation pH, time and pasteurization parameters. The composition can be prepared into multiple dosage forms such as toothpaste and the like, can remarkably inhibit the growth of streptococcus mutans and destroy the thallus structure, inhibits biofilm and exopolysaccharide synthesis by down-regulating fimI, wcaJ and wcae genes, is safe and free of side effects, and provides an efficient scheme for decayed tooth prevention and treatment.
Owner:YANGZHOU PERFECT DAILY CHEM

Compounds and combinations thereof for treating neurological and psychiatric conditions

Dosage forms, drug delivery systems, and methods related to dextromethorphan or improved therapeutic effects are disclosed. Typically, an antidepressant, such as bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Owner:ANTECIP BIOVENTURES II LLC

Nicosulfuron-containing herbicidal composition and application thereof

InactiveCN106172467AReasonable compositionGood weeding effectBiocideDead animal preservationChemical compositionMedicine
The invention discloses a nicosulfuron-containing herbicidal composition and application thereof. The herbicidal composition is prepared from the following components: nicosulfuron, amicarbazone, and dimethyltetrachloroisooctyl ester as well as a dispersant, an emulsifier, a wetting agent, a thickening agent, an antifreeze, and a dispersion medium, wherein the dosage form belongs to a dispersed oil suspension agent. Through the combination of the three active ingredients, the herbicidal composition has an obvious synergistic effect, the use amount of pesticides is reduced, the cost and environmental pollution are reduced, the drug resistance of corn field weeds can be delayed by the application of the composition, and the control spectrum is expanded.
Owner:SHANDONG AOKUN BIOLOGICAL TECH CO LTD

Cordyceps javanica Bd01 and application of dispersible oil suspending agent of cordyceps javanica Bd01 in prevention and control of spodoptera frugiperda

The invention discloses application of cordyceps javanica Bd01 and a dispersible oil suspending agent thereof to prevention and control of spodoptera frugiperda, and relates to the technical field of biology. The research finds that the cordyceps javanica Bd01 has a strong infection lethal effect on larvae of spodoptera frugiperda at all ages, the pupation rate and eclosion rate of the larvae can be remarkably reduced, and the breeding cycle of pests can be effectively blocked. The invention further develops a dispersible oil suspending agent, and the suspending rate is effectively improved through formula optimization. The dosage form takes soybean oil as a dispersion medium, does not contain harmful solvents such as methylbenzene, is free of dust pollution and is friendly to operators and the environment, and ascorbic acid is added to improve the ultraviolet resistance of spores and prolong the effective period of the pesticide effect. In addition, the preparation also has a certain control effect on caffeinidae, is wide in application scene, provides a new scheme for green control of spodoptera frugiperda, solves the problems of chemical pesticide resistance and residue, and accords with the development requirements of green agriculture.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Composite combined preparation for synergistically treating and conditioning diabetes mellitus

The invention discloses a composite combined preparation for synergistically treating and conditioning diabetes, relates to the technical field of foods, health foods or dietary supplements for adjuvant therapy and health care of diabetes, and in particular relates to a composite combined preparation for synergistically treating and conditioning diabetes. The preparation comprises albumin peptide, saussurea involucrata culture, vitamin B1, vitamin B2, wheat oligopeptide, corn oligopeptide, collagen peptide, mulberry leaf extract, rhizoma polygonati extract, sea-buckthorn extract, isomaltitol, maltodextrin, ginseng extract and bitter gourd extract. Through the synergistic effect of all the components, comprehensive auxiliary conditioning on diabetes is realized from multiple targets of maintaining colloid osmotic pressure and nutrition, regulating glycolipid metabolism in multiple ways, protecting pancreatic beta cell functions, enhancing insulin sensitivity, preventing nerve and blood vessel complications, meeting special diet requirements and the like. The composition can be prepared into food, health-care food or dietary supplement and other dosage forms.
Owner:SHANDONG JIEDIAO CARBON SINK CONSTRUCTION ENGINEERING GROUP CO LTD

Deep processing method of black ginseng product

The invention discloses a deep processing method of a black ginseng product. The deep processing method comprises the stages of raw material pretreatment, strain preparation, fermentation and product preparation. In the raw material pretreatment, ginseng is screened, cleaned and graded, and foil-coated and dished; activating, culturing and propagating the strain; controlling parameters such as temperature in a fermentation stage; the black ginseng product is obtained after the fermented ginseng is treated in product preparation. The method adopts a pure natural enzymatic fermentation process, improves the conversion rate of effective components, improves the product quality, enriches dosage forms, is environment-friendly and safe, and has a good prospect.
Owner:FUSONG COUNTY CHUANQI ECOLOGY GINSENG IND CO LTD

Anti-aging capsule compounded by PQQ and mitochondrial nutrients

The invention relates to an anti-aging capsule compounded by PQQ and mitochondrial nutrients, and discloses an anti-aging capsule which is prepared by synergistically compounding a plurality of mitochondrial nutrients according to a scientific proportion and supplementing high-purity raw materials and slow-release dosage forms to realize energy metabolism activation and anti-oxidation synergistic intervention. Therefore, the anti-aging capsule systematically delays aging through multi-target regulation and control of mitochondrial functions. The capsule is characterized by comprising the following components in parts by weight: 1-20 mg of pyrroloquinoline quinone disodium salt (PQQ), 20-100 mg of coenzyme Q10, 50-200 mg of L-carnitine tartrate, 10-100 mg of alpha-lipoic acid, 50-300 mg of nicotinamide mononucleotide (NMN) or nicotinamide nucleoside (NR), and 10-50 [mu] g of selenoprotein or organic selenium yeast, and a capsule carrier comprises 100 mg of gelatin or a plant-derived capsule shell, 180 mg of microcrystalline cellulose, 5 mg of magnesium stearate and 5 mg of silicon dioxide.
Owner:JIANGSU SHAREJOY HEALTH TECH CO LTD

Sensitive skin care composition with soothing, repairing efficacy and use thereof

The present application relates to a kind of sensitive skin care composition with soothing, repair effect and its application, it is composed of 4-tert-butyl cyclohexanol, schisandra chinensis extract and grey hair bean seed extract, the mass ratio of 4-tert-butyl cyclohexanol, schisandra chinensis extract and grey hair bean seed extract is 1:(0.01-0.1):(0.01-0.1);Wherein, schisandra chinensis extract and grey hair bean seed extract are obtained using enzymatic hydrolysis-fermentation process, the composition of the present application has good soothing repair effect, and the active ingredient combination shows good compatibility and stability in formula system, without additional solubilizer and emulsifier, adapt more mild dosage form, more fit the needs of moderate sensitive skin.
Owner:N O D TOPIA (GUANGZHOU) BIOTECHNOLOGY CO LTD

Dry powder composition for peroral administration

There is provided a pharmaceutical dosage form that is suitable for peroral administration to the gastrointestinal tract, which dosage form comprises a pharmaceutical composition in the form of a particulate mixture comprising solid particles of N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide (C21), or a pharmaceutically-acceptable salt thereof, admixed with a blend of carrier particles with weight- and / or a volume-based mean diameter, and / or a structural / particle density, that is / are similar to the weight- and / or volume-based mean diameter, and / or the structural / particle density, of the solid particles of C21, and a glidant, which composition is contained within a capsule that is suitable for such peroral administration. Preferred carrier particles have a weight- and / or a volume-based mean diameter that is less than about 100 μm. Preferred carrier particle materials include mannitol. Preferred glidants comprise colloidal silica. Such dosage forms find utility in the treatment of lung diseases, such as idiopathic pulmonary fibrosis, sarcoidosis and respiratory virus-induced tissue damage.
Owner:VICORE PHARMA AB

Pharmaceutical composition

To provide a technology that suppresses the strong bitter taste of rebamipide in various dosage forms of formulations. [Solution] A pharmaceutical composition containing rebamipide, an organic acid (excluding amino acids), and an amino acid.
Owner:DOJIN IYAKU KAKO CO LTD

Pharmaceutical dosage form comprising lanosterol and derivatives thereof and cyclodextrin

The present invention relates to a pharmaceutical dosage form comprising lanosterol and a derivative thereof, and cyclodextrin, the pharmaceutical dosage form according to one embodiment having an effect of improving water solubility and in vivo absorbability, thereby increasing bioavailability.
Owner:CARBOEXPERT INC

Improved oral preparation based on traditional Chinese medicine prescription Yufengxiangshan and preparation method of oral preparation

The invention relates to the technical field of oral preparations, in particular to an improved oral preparation based on traditional Chinese medicine prescription Yufengxiang powder and a preparation method of the oral preparation. The preparation comprises traditional Yufengxiang powder components such as mung beans, radix angelicae, Chinese wolfberry fruits, licorice roots and poria cocos. And modern functional components such as turmeric, grape seeds, low-molecular-weight hyaluronic acid, L-ascorbic acid, zinc gluconate, a pumpkin seed extract, black pepper pigment and a rice essence extract. The preparation method comprises the following steps: respectively extracting the raw materials, drying into powder, mixing all active components according to the formula, controlling the moisture content of the powder, and filling into an enteric capsule shell. Through dosage form improvement and formula optimization, the bioavailability of active ingredients is remarkably improved, multiple synergistic effects of whitening, oxidation resistance, moisturizing, nerve soothing, alopecia improvement and the like are achieved, and the technical problems that traditional Yufeng western style powder is low in external use absorption rate and single in function are solved.
Owner:WUXI MEIYI BIOTECHNOLOGY CO LTD

Traditional Chinese medicine for treating protrusion of lumbar intervertebral disc

The invention provides a traditional Chinese medicine for treating protrusion of lumbar intervertebral disc, and relates to the technical field of traditional Chinese medicines. Aiming at the core pathogenesis of qi stagnation and blood stasis, deficiency of liver and kidney and cold-dampness arthralgia of the lumbar intervertebral disc protrusion, a synergistic compatibility concept of promoting blood circulation to remove blood stasis, tonifying liver and kidney, dispelling cold-dampness and activating meridians to stop pain is adopted. The traditional Chinese medicine is prepared from 12 traditional Chinese medicines such as ligusticum wallichii, safflower, eucommia ulmoides and radix achyranthis bidentatae through an optimized process of crushing, extracting, concentrating and forming, and the dosage form comprises tablets, capsules or oral liquid. The core innovation lies in accurate matching of the formula, multi-target synergistic effect is achieved, and the problems that traditional Chinese medicine is slow in curative effect and poor in pertinence are solved. Clinical verifications show that the traditional Chinese medicine can relieve lumbar pain within 7 days and improve symptoms such as numbness of lower limbs and limited movement within 1-2 treatment courses, has the total effective rate of greater than or equal to 92%, is safe, has no obvious toxic or side effect, is suitable for patients with different types of lumbar disc herniation, and is convenient to take and high in cost performance.
Owner:GANSU XINGLIN CHUNXIAO MEDICAL TECHNOLOGY CO LTD

Dispensing system including a dispensing device and method for managing dosage form information using the dispensing system

The present invention relates to a method for managing dosage form information performed by a dispensing system that includes a dispensing device configured to dispense dosage forms by mounting cartridge modules containing dosage forms, and the present invention states that by updating the remaining dosage amount information of the dosage form remaining in a cartridge module removed from the dispensing device with the remaining dosage amount information of the dosage form contained in a newly mounted cartridge module of the dispensing device, the convenience of management and the convenience of use by the user can be improved when managing the remaining dosage amount information of dosage forms.
Owner:アルゴケア コーポレイション

A traditional Chinese medicine composition for treating male infertility of liver stagnation and kidney deficiency type, a preparation method and application thereof

PendingCN122398881ASerum pharmacochemistryKidney
This invention discloses a traditional Chinese medicine composition for treating male infertility due to liver stagnation and kidney deficiency, its preparation method, and its application, belonging to the fields of traditional Chinese medicine pharmaceutical technology and andrological reproductive health technology. The composition is formulated with Bupleurum chinense, Tribulus terrestris, Cynomorium songaricum, Cuscuta chinensis, Cornus officinalis, and Epimedium brevicornu in specific weight proportions, following the principles of soothing the liver and relieving stagnation, tonifying the kidney and replenishing essence, and unblocking the meridians to treat impotence. This invention employs an alcohol-water dual-phase fractional extraction process, and can be prepared into various dosage forms such as granules, capsules, and tablets. Pharmacological experiments have confirmed that the composition of this invention can increase sperm density and progressively motile sperm rate, improve penile tissue nitric oxide synthase (NOS) activity, regulate reproductive hormones, and reduce testicular oxidative damage; serum pharmacochemistry and metabolomics have clarified the active components entering the bloodstream and their pathways of action. This invention features a refined formulation, abundant medicinal resources, and simple preparation, making it suitable for large-scale production and clinical application in treating male infertility due to liver stagnation and kidney deficiency.
Owner:GUIZHOU MEDICAL UNIV